Home
Conditions
HER2-low Breast Cancer

Clinical trial condition

HER2-low Breast Cancer

Explore clinical trials studying HER2-low Breast Cancer. Study availability and eligibility vary by location and protocol.

10 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

HER2-low Breast Cancer trial results

Recruiting

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

NCT07383506

Conditions: Advanced Solid Tumors, Adult, Breast Diseases, Breast Neoplasms, +18 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

Washington University School of Medicine - Siteman Cancer Center St Louis, Missouri, United States

NEXT Austin Austin, Texas, United States

NEXT Virginia Fairfax, Virginia, United States

View Trial Details

Recruiting

Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study

NCT07446452

Conditions: HER2-low Breast Cancer
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer

NCT07358182

Conditions: HER2-low Breast Cancer, HER2-positive Breast Cancer, Trastuzumab-rezetecan
Locations: Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-low Recurrent/Metastatic Breast Cancer

NCT06957886

Conditions: HER2-low Breast Cancer
Locations: Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China

Hunan Cancer Hospital Changsha, Hunan, China

View Trial Details

Recruiting

A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)

NCT06210776

Conditions: Advanced Cancer, Breast Cancer, Breast Diseases, +7 more
Locations: China-Japan Friendship Hospital Beijing, China

Peking University First Hospital Beijing, China

The Fifth Medical Center of the Chinese PLA General Hospital Beijing, China

Peking University Shougang Hospital Beijing, China

View all 54 locations

View Trial Details

Recruiting

HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC

NCT06830382

Conditions: Breast Cancer Stage IV, Breast Diseases, Breast Neoplasms, +6 more
Locations: Karolinska University hospital Solna, Sweden

View Trial Details

Recruiting

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

NCT06533826

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: University of Alabama Birmingham, Alabama, United States

University of San Francisco San Francisco, California, United States

Yale University Cancer Center New Haven, Connecticut, United States

Georgetown University Medical Center Washington D.C., District of Columbia, United States

View Trial Details

Recruiting

Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer

NCT05466786

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer

NCT06877416

Conditions: Antibody-drug Conjugates, Breast Diseases, Breast Neoplasms, +5 more
Locations: Sun yat-sen University Cancer Guangzhou, Guangdong, China

View Trial Details

Completed

Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer

NCT06040593

Conditions: HER2-low Breast Cancer, HER2-negative Breast Cancer, Hormone-receptor-positive Breast Cancer
Locations: ConcertAI database Cambridge, Massachusetts, United States

View Trial Details

HER2-low Breast Cancer

HER2-low Breast Cancer trial results

Related conditions